New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches, Benef. Microbes, vol.9, pp.317-331, 2018. ,
A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces, FEMS Microbiol. Lett, vol.363, p.117, 2016. ,
Improved cloning vectors for bifidobacteria, based on the bifidobacterium catenulatum pBC1 replicon, Appl. Environ. Microbiol, vol.74, pp.4656-4665, 2008. ,
Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces, J. Biotechnol, vol.168, pp.120-129, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01004637
Engineering lactococci and lactobacilli for human health, Curr. Opin. Microbiol, vol.16, pp.278-283, 2013. ,
Bifidobacterium, " in Bergey's Manual of Systematics of Archaea and Bacteria, 2015. ,
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease, Clin. Gastroenterol. Hepatol, vol.4, pp.754-759, 2006. ,
Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-?B pathway, Front. Microbiol, vol.8, p.114, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01604976
Clinicopathologic study of dextran sulfate sodium experimental murine colitis, Lab. Invest, vol.69, pp.238-249, 1993. ,
A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum, Biotechnol. Lett, vol.29, pp.1249-1253, 2007. ,
Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat. Rev. Gastroenterol. Hepatol, vol.11, pp.506-514, 2014. ,
Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve, Arch. Microbiol, vol.192, pp.769-774, 2010. ,
Survival of lactococci during passage through mouse digestive tract, Can. J. Microbiol, vol.49, pp.707-711, 2003. ,
Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction, J. Biol. Chem, vol.270, pp.27299-27304, 1995. ,
Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects, Future Microbiol, vol.11, pp.585-600, 2016. ,
Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy, Cancer, vol.119, pp.4268-4276, 2013. ,
Cloning and expression of synthetic genes encoding angiotensin-I converting enzyme (ACE)-inhibitory bioactive peptides in Bifidobacterium pseudocatenulatum, FEMS Microbiol. Lett, vol.340, pp.24-32, 2013. ,
Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation, Hum. Vaccines Immunother, vol.10, pp.1611-1621, 2014. ,
Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants, Appl. Environ. Microbiol, vol.74, pp.660-666, 2008. ,
Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion, J. Mol. Microbiol. Biotechnol, vol.14, pp.48-58, 2008. ,
Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis, Sci. Transl. Med, vol.4, pp.158-144, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01204261
Antimicrobial susceptibility of bifidobacteria, J. Antimicrob. Chemother, vol.55, pp.38-44, 2005. ,
Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria, Clin. Diagn. Lab. Immunol, vol.10, pp.696-701, 2003. ,
Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis, Appl. Environ. Microbiol, vol.76, pp.3048-3051, 2010. ,
Molecular Cloning: a Laboratory Manual, 1989. ,
Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809, J. Bacteriol, vol.187, pp.5799-5808, 2005. ,
The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.14422-14427, 2002. ,
Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003, Microbiology, vol.153, pp.3563-3571, 2007. ,
Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine, Hum. Vaccines Immunother, vol.0, pp.1-4, 2017. ,
Structural and biological stability of the human interleukin 10 homodimer, Biochemistry, vol.37, pp.16943-16951, 1998. ,
Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice, Vaccine, vol.32, pp.3066-3074, 2014. ,
An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis, Am. J. Physiol. Gastrointest. Liver Physiol, vol.258, pp.527-534, 1990. ,
Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71, Arch. Virol, vol.158, pp.1071-1077, 2013. ,
Oral Bifidobacterium longum expressing GLP-2 improves nutrient assimilation and nutritional homeostasis in mice, J. Microbiol. Methods, vol.145, pp.87-92, 2018. ,